ImmunitoAI

AI-powered platform for efficient Antibody Drug Design

description

immunitoAI is a biotech startup that aims to make targeted therapy using antibodies a norm. It is developing an AI-powered platform for antibody discovery and screening. The platform screens and ranks the best antibody candidates for a given target/antigen. With this technology, the discovery process can be made 2x more efficient while improving the success rate.

founders

Aridni Shah
Trisha Chatterjee

founded

2020

year of investment

Sep 2021

"

why we invested

Antibodies are promising drug candidates but have a long, inefficient discovery and development process. Immunito is disrupting this space with their AI platform that generates novel antibodies for any given protein target.

"

Latest on

ImmunitoAI

September 21, 2021
ImmunitoAI: AI powered Antibody Discovery & Screening

More from the

folio

Alternative protein using precision fermentation
Life Sciences
Materials
AI chatbot providing accessible mental health therapy.
AI
AI assistant to streamline operations for small businesses
AI